January’s top 10 features technological advancements, with Cook Medical receiving US Food and Drug Administration (FDA) approval for new drug-eluting stents and Adept Medical launching Lower Leg Support for patients with peripheral artery disease. In addition, Inari Medical announced positive six-month FLASH registry patient outcome data following treatment of pulmonary embolism with FlowTriever, and Ajax Health has appointed two leading cardiovascular professionals to Cordis-X.
1) Cook Medical receives FDA breakthrough designation for new drug-eluting stent
Cook Medical has received breakthrough device designation from the US Food and Drug Administration (FDA) on a new drug-eluting stent for below the knee. This new stent is designed to treat patients suffering from chronic limb-threatening ischaemia.
2) Fundamental IR techniques help provide invaluable treatment options for animals
Peter Littler (Newcastle, UK) talks to Gerard McLauchlan (Surrey, UK) and Alex Horton (Surrey, UK) regarding veterinary interventional radiology (IR) following a special session titled “All Creatures Great and Small: IR for animals” at the British Society of Interventional Radiology annual scientific meeting (8–10 December, Glasgow, UK).
3) Adept Medical launches Lower Leg Support for PAD patients
Adept Medical has unveiled the Lower Leg Support solution, which is designed to assist with peripheral artery disease (PAD) interventions.
4) ISET 2022 audience hears latest data on endovascular therapies
At this year’s International Symposium on Endovascular Therapy (ISET 2022; 16–19 January, Hollywood, USA), experts presented an array of late-breaking trial results on topics ranging from venous stenting to abdominal aortic aneurysm sac sealing.
5) Improving interdepartmental communication to avoid forgotten ureteric stents
There are some very serious risks associated with forgotten ureteric JJ stents. David Maudgil, a consultant interventional radiologist at Wexham Park Hospital, Frimley Health Foundation Trust (Slough, UK), outlines why and when these devices are used, explains the risks a forgotten stent might pose, and provides some guidance on how to mitigate such risks.
6) Embolization comes knocking on knee pain’s door
A wealth of data emerging in the last 18 months, including from a small multicentre, randomised study of genicular artery embolization for knee pain secondary to osteoarthritis, brings a glimpse of other similar minimally invasive options to treat disability in the entire musculoskeletal system. Embolization, which is rapidly surfacing as a safe and effective procedure for the treatment of patients with osteoarthritis of the knee, has been shown to be technically achievable, with very promising outcomes at early follow-up.
7) Philips integrates cloud-based AI and 3D mapping into its mobile C-arm system series
Royal Philips has announced physicians will now have access to advanced new 3D image guidance capabilities through the image-guided therapy mobile C-arm system—Zenition, aiming to improve the outcomes for patients undergoing endovascular treatment. The company has signed a strategic partnership agreement with Cydar, a provider of cloud-based procedure maps software to plan and guide surgery in real-time.
8) BD launches Crosser iQ CTO recanalisation system
BD (Becton, Dickinson, and Company) has announced the launch and 510(k) clearance from the US Food and Drug Administration (FDA) of the Crosser iQ chronic total occlusion (CTO) recanalisation system, which is designed to cross peripheral artery CTOs intraluminally.
9) Six-month registry interim data flash early thrombectomy safety in pulmonary embolism patients
Inari Medical has announced positive acute and long-term interim results from the first 500 pulmonary embolism patients enrolled in the FlowTriever outcomes registry (FLASH).
10) Jeremy Durack and John Simpson to join Cordis-X innovation accelerator
Ajax Health has announced the appointments of two cardiovascular professionals to Cordis-X, an independent accelerator created to drive innovation and growth to Cordis.
